3 test combo to treat AD?

Share this article:

Combining diagnostic tests that include imaging and cerebrospinal fluid biomarkers can improve prediction of a patient progressing from mild cognitive impairment to Alzheimer's disease, according to a study published Dec. 11 in Radiology.

Duke Medicine researchers reviewed three tests — magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis — to learn whether the trio were more accurate than single tests. The study subjects also were given routine clinical exams.

Share this article:
close

Next Article in News

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...